Loading...
*  Cell Cycle - QIAGEN
Cell cycle progression is regulated by the cyclic rise and fall of kinase expression, and their interaction with, and action on ... How Can We Fight an Ancient Disease? * How Can We Keep Animals Healthy? ... Cell cycle progression is regulated by the cyclic rise and fall of kinase expression, and their interaction with, and action on ... Key genes that regulate cell cycle progression and checkpoints encode cullins, cyclins, and cyclin-dependent kinases and their ...
  https://www.qiagen.com/cn/shop/genes-and-pathways/complete-biology-list/cell-cycle/
*  Intermittent Taxotere® Effective in Hormone-refractory Prostate Cancer
... men who received CA Taxotere administered once every three weeks or IA Taxotere administered at measurable cancer progression ... Disease Specific Sites *Brain Cancer Sites. *Breast Cancer Sites. *Chemotherapy Sites. *Childhood Cancer Sites ...
  http://cancer.unm.edu/2009/03/08/intermittent-taxotere-effective-in-hormone-refractory-prostate-cancer/
*  Papers with the keyword late-stage neuroendocrine prostate cancer | Read by QxMD
... and 15 metastatic tumors from 72 patients at different stages of disease progression to t-NEPC, some with multiple specimens... ... BACKGROUND: Animal models that closely mimic clinical disease can be exploited to hasten the pace of translational research. To ... Circulating tumor cells capture disease evolution in advanced prostate cancer.. Justin Lack, Marc Gillard, Maggie Cam, Gladell ... Neuroendocrine (NE)-like cells are hypothesized to contribute to the progression of prostate cancer by producing factors that ...
  https://www.readbyqxmd.com/keyword/115753
*  Vascular Targeted Photodynamic Therapy with Padeliporfin for Low Risk Prostate Cancer Treatment: Midterm Oncologic Outcomes.,...
Disease Focus. Read carefully compiled disease summaries which detail how our system of categorisation is put together. ... Progression-free survival is reported with Kaplan-Meier curves.. Results: A total of 82 men were treated with vascular targeted ... Median followup was 68 months (range 6 to 89). Median progression-free survival was 86 months (95% CI 82-90). Median prostate ... The primary end point was progression-free survival. Secondary end points were absent clinically significant cancer in the ...
  https://www.epgonline.org/uk/journals/vascular-targeted-photodynamic-therapy-with-padeliporfin-for-low-risk-prostate-cancer-treatment--mid.html
*  MAPK Usage in Periodontal Disease Progression
... signaling axis is needed for periodontal disease progression: an orally administered p38α inhibitor reduced the progression of ... MAPK Usage in Periodontal Disease Progression. Qiyan Li,1 Michael S. Valerio,2 and Keith L. Kirkwood2 ... MAPK phosphatase-1 (MKP-1), a negative regulator of MAPK activation, was also critical for periodontal disease progression. In ... these studies highlight the importance of p38 MAPK signaling in immune cytokine production and periodontal disease progression. ...
  https://www.hindawi.com/journals/jst/2012/308943/abs/
*  Parkinson's: Could this existing drug halt disease progression?
... that is commonly used to treat tapeworm infections is found to contain a molecule that can protect against Parkinson's disease. ... Parkinson's disease may begin in the gut Parkinson's disease may start in the gut, suggest researchers. The neurogenerative ... The findings bring us closer to slowing or even stopping neurodegeneration in this disease.. An existing drug may soon be used ... "We will now take our findings to the next level by evaluating the ability of niclosamide to treat Parkinson's disease in ...
  https://www.medicalnewstoday.com/articles/320356.php
*  Guanabenz Accelerates ALS Disease Progression in Preclinical Laboratory Experiments
In these studies from the Institute, treatment of SOD1 mice with guanabenz actually accelerated disease progression. These ... in ALS disease progression. While most ALS has not yet been linked to specific genetic mutations, at least 10% of cases have ... Led by ALS patients and their families, the charity understands the urgent need to slow and stop this horrible disease. Based ... research reports have suggested a neuroprotective effect by guanabenz in SOD1 mice resulting in slower disease progression and ...
  http://www.prweb.com/releases/2015/08/prweb12911582.htm
*  NSCLC Combo Slows Disease Progression | Medpage Today
Progression of non-squamous non-small cell lung cancer slowed by almost half when pemetrexed (Alimta) and erlotinib (Tarceva) ... The progression hazard ratio was 0.57 for the comparison with erlotinib alone (P=0.002) and 0.58 for the comparison with ... Progression of non-small cell lung cancer slowed by almost half when pemetrexed (Alimta) and erlotinib (Tarceva) were used in ... VIENNA -- Progression of non-squamous non-small cell lung cancer (NSCLC) among never- and former light-smoker patients slowed ...
  https://www.medpagetoday.com/meetingcoverage/esmo/35190
*  Receptor Mutations Help Slow Disease Progression | Science
Population geneticist Stephen O'Brien of the National Cancer Institute and a large group of collaborators have amassed strong confirmatory evidence that people who have two mutant copies of the gene for a chemokine receptor known as CCR5 (also known as CKR5) are highly resistant to HIV infection. The findings, published on page1856 , also indicate that people who do get infected with HIV, but have one mutant copy of the CCR5 gene, progress to AIDS more slowly than do people without the mutation.. ...
  http://science.sciencemag.org/content/273/5283/1797
*  Lou Gehrig's disease progression: | Sciforums
Researchers show how Lou Gehrig's disease progression could be delayed February 9, 2017 [IMG] Pellecchia and colleagues ... Researchers show how Lou Gehrig's disease progression could be delayed. February 9, 2017. Please Register or Log in to view the ... Lou Gehrig's disease progression:. Discussion in 'Biology & Genetics' started by paddoboy, Feb 9, 2017. ... sometimes known as Lou Gehrig's disease, the neurodegenerative disease that affects motor neurons - nerve cells in the brain ...
  http://sciforums.com/threads/lou-gehrigs-disease-progression.158870/
*  Occasional Heroin Use Impacts HIV Disease Progression
Occasional heroin use by HIV-positive patients may be harmful to the immune system and worsen HIV disease, compared to ... E. Jennifer Edelman and her co-authors were interested in whether heroin use impacted HIV disease progression. 77 HIV-infected ... "AIDS is an epidemic disease, a potentially preventable, deadly infection for which there is no cure, no vaccine, and it is not ... The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always ...
  http://www.medindia.net/news/occasional-heroin-use-impacts-hiv-disease-progression-144938-1.htm
*  Atherosclerosis Disease Progression Cell Markers
To get started with seeing how the Atherosclerosis Disease Progression Cell Markers tool can benefit you, follow these easy ... Detail from the Atherosclerosis Disease Progression Cell Markers tool. Phenotyping links connect to antibodies validated for ... Home » Resources » Blog » Atherosclerosis Disease Progression Cell Markers. Atherosclerosis Disease Progression Cell Markers. ...
  https://www.rndsystems.com/blog/atherosclerosis-disease-progression-cell-markers
*  Vitamin E may slow Alzheimer's disease progression | HeraldNet.com
Researchers say vitamin E might slow the progression of mild-to-moderate Alzheimer's disease - the first time any treatment has ... Researchers say vitamin E might slow the progression of mild-to-moderate Alzheimer's disease - the first time any treatment has ... Antioxidants help protect cells from damage that can contribute to other diseases, says the federal Office on Dietary ... "The best we can do at this point is slow down the rate of progression." ...
  http://www.heraldnet.com/news/vitamin-e-may-slow-alzheimers-disease-progression/
*  Small Markers May Pinpoint Disease Progression
... and looked at the clinical symptoms to find markers that might show the odds for disease progression. The results showed that ... did not help in predicting disease progression. Positive rheumatoid factor (an antibody detected in a blood test), some genetic ... Also, 48% of the patients did not develop progressive disease. (These findings were published in Arthritis & Rheumatism, ... disease state management, patient counseling, product news, pharmacy law and health-system pharmacy. Pharmacy Times Continuing ...
  http://www.pharmacytimes.com/publications/issue/2004/2004-03/2004-03-7718
*  disease progression Archives ~ HCV Advocate
HCV Disease Progression. Click on a title below to view or download the PDF about that subject.. Overview of HCV Disease ... Filed Under: Espanol, Publications, Spanish Tagged With: cirrhosis, disease progression, fact sheets, fibrosis, steatosis ... Studies have found that the combination of hepatitis C and steatosis increases the risk of HCV disease progression and may ... Filed Under: Factsheets, Publications Tagged With: cancer, cirrhosis, disease progression, fibrosis, steatosis ...
  http://hcvadvocate.org/tag/disease-progression/
*  Vitamin E may slow Alzheimer s disease progression
Researchers say vitamin E might slow the progression of mild-to-moderate Alzheimer s disease the first time any treatment has ... Vitamin E may slow Alzheimer's disease progression. Associated Press Alexis McKenzie, right, executive director of The ... Researchers say vitamin E might slow the progression of mild-to-moderate Alzheimer s disease the first time any treatment has ... researchers report that vitamin E might slow the progression of mild to moderate Alzheimer s disease. The study of more than ...
  http://www.dailylocal.com/lifestyle/20140106/vitamin-e-may-slow-alzheimers-disease-progression
*  Medical Xpress - disease progression
Medical Xpress is a web-based medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and conditions, medications and more.
  https://medicalxpress.com/tags/disease+progression/sort/date/12h/
*  Frontiers | Parkinson's Disease: Cell Vulnerability and Disease Progression
The hallmark feature of this disease is the degeneration of dopamine neurons in the... ... Parkinson's disease is a neurodegenerative disorder that affects 1.5% of the global population over 65 years of age. ...
  https://www.frontiersin.org/books/Parkinson_s_Disease_Cell_Vulnerability_and_Disease_Progression/754
*  HCV /HIV Nonresponders Experience Improved Disease Progression
Does Interferon Slow HCV Disease & Improve Survival. Interferon therapies are associated with significant side effect profiles ... This finding was secondary to the reduction in risk of death from liver disease in the treated group as the risk of dying from ... 86 deaths were noted amongst the group with 58 (67%) attributable to liver disease. 39 deaths were due to liver cancer, 12 ... degree of liver disease on biopsy or resting energy expenditure. This study highlights two important points. The first is that ...
  http://www.natap.org/2002/DDWLiver/day10.htm
*  Biomarkers of Periodontal Disease Progression - Full Text View - ClinicalTrials.gov
Disease Progression. Periodontal Diseases. Gingival Diseases. Disease Attributes. Pathologic Processes. Mouth Diseases. ... The primary study outcome will be progression of periodontal disease as determined by CAL. Initial disease progression at a ... Subsequent disease progression will be similarly defined except that the loss in CAL will be compared with the last visit at ... Biomarkers of Periodontal Disease Progression. This study is ongoing, but not recruiting participants. ...
  https://clinicaltrials.gov/ct2/show/NCT01489839?recr=Open&cond=%22Periodontal+Diseases%22&rank=4
*  Disintegrating brain lesions could predict disease progression in MS patients
... the appearance of new or expanding brain lesions on magnetic resonance imaging scans as a sign that a patient's disease is ... Disintegrating brain lesions could predict disease progression in MS patients. *Download PDF Copy ... "Using the appearance of new brain lesions and the enlargement of existing ones as the indicator of disease progression, there ... typically seen as indicators of disease progression. Approval by the Food and Drug Administration for new MS drugs typically ...
  https://www.news-medical.net/news/20180605/Disintegrating-brain-lesions-could-predict-disease-progression-in-MS-patients.aspx
*  Finasteride Reduces Symptoms And Disease Progression Associated With Enlarged Prostates - Redorbit
Finasteride Reduces Symptoms And Disease Progression Associated With Enlarged Prostates. by Sam Savage ... and reduces disease progression. This conclusion comes from combining the findings of 23 randomized clinical trials that ... Drugs like finasteride are frequently prescribed to improve LUTS and reduce long-term symptom progression, including the risk ...
  http://www.redorbit.com/news/health/1928234/finasteride_reduces_symptoms_and_disease_progression_associated_with_enlarged_prostates/
*  Tau Timing: New Findings on Disease Progression, Clearance | ALZFORUM
reveals that CSF phospho-tau levels and the rate of disease progression in AD subjects are strongly correlated to the presence ... Finding that tau levels are connected to disease progression fits well with previous research, said Henrik Zetterberg at ... but also with a faster rate of progression of AD. This finding supports the idea that tau increases the severity of the disease ... activation of the mechanism of modified tau clearance by inhibiting rather than activating Sirt1 early in disease progression ...
  http://www.alzforum.org/news/research-news/tau-timing-new-findings-disease-progression-clearance
*  UAB - News - Synthetic antioxidant slows kidney disease progression
New drug may slow the progression of chronic kidney disease in type 2 diabetics, increase kidney function and stave off ... A new drug has the potential to slow the progression of chronic kidney disease in Type 2 diabetics while increasing kidney ... New drug may slow the progression of chronic kidney disease in type 2 diabetics, increase kidney function and stave off ... In the 52-week, double-blind study, 227 patients with moderate to severe chronic kidney disease and Type 2 diabetes were given ...
  http://www.uab.edu/news/latest/item/1372-synthetic-antioxidant-slows-kidney-disease-progression
*  Proteins May Determine Disease Progression | The Daily Nexus
Through counteracting chronic inflammation, the progression of the disease could be prevented. Thus, the researchers' goal was ... which contributes to the progression of the disease.". However, after inducing the ER stress, the researchers treated the mice ... researched the phenomena of protein folding in relation to disease progression. Their research was guided by the idea that a ... Rather, it has the potential to prevent the progression of it.. In addition, Acosta-Alvear and his team have many more years of ...
  http://dailynexus.com/2017-02-16/proteins-may-determine-disease-progression/